The first step of any public health response must be prevention. Preventing new infections and containing the pandemic protects health systems from getting close to collapse.
Academic rigour, journalistic flair
Articles on Public health
Displaying 641 - 660 of 2119 articles
CC BY-NC-ND16.7 MB (download)
Is it possible for COVID-19 to help us shape a better world?
South Africa is quite capable of delivering world-class healthcare to all its citizens. But this is constantly being hampered by an increasingly unconducive environment.
To come out of lockdown, health authorities want to see that all cases are linked, and that potentially infectious people are quarantining before they test positive. This still isn’t happening.
Patients shouldn’t be treated better simply because they can afford to pay more.
The presence of multi drug-resistant bacteria in goats and sheep in southwest Nigeria may be due to regular use of antibiotics and unhygienic practices by farmers.
Vaccine manufacturing doesn’t come cheap. It depends heavily on support from developed countries. It also requires much more than relaxing intellectual property rights and a desire for vaccine equity.
If universities produce graduates who can work effectively in a team, the healthcare system will be strengthened and this would improve the health outcomes for patients.
How well are the Tokyo Olympics prepared for a COVID crisis when there is still an outbreak in the country, the vaccination rates are low and athletes are asked to socially distance?
For those desperate for international holidays, there is light at the end of the tunnel.
There is an urgent need for legislation dealing specifically with electronic waste in Nigeria.
Even when we immunise all Australians who want to be protected against COVID-19, we’re unlikely to achieve herd immunity through vaccination alone. We need three other measures to open our borders.
The strong disapproval of the South African government’s handling of the pandemic is a warning that crafting persuasive pro-vaccine messages is not enough.
Relying on donor funding means that the funder ultimately determines the health priorities. This is one reason why many programmes in Africa focus on a single disease such as HIV.
The rule, which previously acted as the upper time limit on human embryo research, has been dropped, paving the way for research on older human embryos.
South Africa didn’t engage early enough with pharmaceutical companies in bilateral discussions to ensure it could get vaccines early.
Failure to identify, understand and address the implications of unintended consequences inhibits the delivery of quality healthcare.
National policies must incorporate good practices derived from lessons learnt so far to strengthen their health systems. Critical policy elements include preparedness and response.
South Africa needs a public health response that expands the successes of the country’s HIV testing and treatment programme to provide care for multiple diseases.
Having survived the HIV/AIDS pandemic, gay communities in the US were well equipped to get residents health and social services early in the pandemic, when the government’s COVID-19 response lagged.
Job Board
-
Project Offier - Diversity & Inclusion
-
Senior Lecturer - Earth System Science
-
Sydney Horizon Educators (Identified)
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
Top contributors
-
Emeritus Professor in Public Health, University of Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Research Scientist, African Population and Health Research Center
-
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
-
Executive Secretary, Nigerian Academy of Science
-
Medical scientist, National Institute for Communicable Diseases
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Distinguished Professor in the Department of Medicine and Director, The Centre for Medical Ethics & Law, Stellenbosch University
-
Fellow, Nigerian Academy of Science
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Communications Specialist, University of California, San Francisco
-
Associate Professor, Epidemiology, Deakin University
-
Professor of medicine and deputy director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town
